Unimicron Technology (3037) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
9 Nov, 2026Executive summary
Q3-26 sales reached NT$52,650 million, up 23% QoQ and 55% YoY; gross margin was 28.8%.
Net income was NT$10,420 million, down 22% QoQ but up 325% YoY; AI data center applications led reported application growth.
Financial highlights
Net sales were NT$52,650 million; cost of sales was NT$37,461 million and gross profit was NT$15,189 million.
Operating income was NT$10,528 million, up 58% QoQ and 587% YoY; net income was NT$10,420 million.
Income before tax was NT$13,163 million; income tax expense was NT$2,743 million.
Comprehensive income was NT$10,704 million, down 21% QoQ and up 130% YoY.
Segment performance
Substrates represented 62% of Q3 sales, with sales up 26% QoQ and 69% YoY; HDI represented 27%, up 22% QoQ and 52% YoY.
PCB represented 9% of Q3 sales, up 18% QoQ and 12% YoY; FPC represented 1%, down 20% QoQ and 23% YoY.
AI data center applications accounted for 68% of Q3 sales, with sales up 35% QoQ and 115% YoY; communication accounted for 24%, up 28% QoQ and 14% YoY.
Automotive application sales grew 23% QoQ and declined 10% YoY; IoT sales declined 5% QoQ and 9% YoY.
Latest events from Unimicron Technology
- Net profit soared to $18.7B on $80.3B revenue, driven by ABF substrates and asset sales.3037
Q2 2026 - Q1 2026 net sales and income surged, led by substrate, automotive, and strategic investments.3037
Q1 2026 - Sales and net income rose sharply, driven by substrate and automotive growth, with higher cash reserves.3037
Q4 2025 - Net sales up 12% to NT$96.55B, net income down 38%, with new bonds and HK listing planned.3037
Q3 2025 - Revenue up 15% but profit and margins fell sharply amid major merger and FX risks.3037
Q2 2025 - Sales up 13.8% in Q3 2024, but net income and margins declined amid expansion efforts.3037
Q3 2024 - Revenue rose but profit and margins fell due to higher costs and margin pressure.3037
Q2 2024 - Q1 2025 revenue rose 14% year-over-year, but net income and margins declined.3037
Q1 2025 - Sales up 11%, net income down 55–58%, dividend proposed, inventory risk persists.3037
Q4 2024